Opaleye Management Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$9,174,000
+42.8%
191,000
+0.5%
1.80%
-22.5%
Q3 2019$6,426,000
-36.9%
190,000
-16.1%
2.32%
-25.2%
Q2 2019$10,187,000
+26.6%
226,388
+5.9%
3.10%
+39.4%
Q1 2019$8,047,000
+23.4%
213,800
+12.5%
2.23%
-8.4%
Q4 2018$6,520,000
-22.9%
190,000
+5.6%
2.43%
+13.1%
Q3 2018$8,460,000
+39.4%
180,0000.0%2.15%
+37.0%
Q2 2018$6,071,000
+54.8%
180,000
+24.1%
1.57%
+40.0%
Q1 2018$3,923,000145,0001.12%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders